0000920465-20-000013.txt : 20200113
0000920465-20-000013.hdr.sgml : 20200113
20200113161750
ACCESSION NUMBER: 0000920465-20-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200109
FILED AS OF DATE: 20200113
DATE AS OF CHANGE: 20200113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Craig A
CENTRAL INDEX KEY: 0001370348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 20523957
MAIL ADDRESS:
STREET 1: C/O PURE BIOSCIENCE
STREET 2: 1725 GILLESPIE WAY
CITY: EL CAJON
STATE: CA
ZIP: 92020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_157895025331000.xml
FORM 4
X0306
4
2020-01-09
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001370348
Johnson Craig A
C/O LA JOLLA PHARMACEUTICAL COMPANY,
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (Right to Buy)
5.25
2020-01-09
4
A
0
30000
0
A
2030-01-09
Common Stock
30000.0
30000
D
The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
/s/ Ryan Murr, by power of attorney for Craig A. Johnson
2020-01-13